The value of antimicrobial peptides in the age of resistance.

MLA

Magana, Maria, et al. “The Value of Antimicrobial Peptides in the Age of Resistance.” The Lancet. Infectious Diseases, vol. 20, no. 9, Sept. 2020, pp. e216–30. EBSCOhost, https://doi.org/10.1016/S1473-3099(20)30327-3.

APA

Magana, M., Pushpanathan, M., Santos, A. L., Leanse, L., Fernandez, M., Ioannidis, A., Giulianotti, M. A., Apidianakis, Y., Bradfute, S., Ferguson, A. L., Cherkasov, A., Seleem, M. N., Pinilla, C., de la Fuente-Nunez, C., Lazaridis, T., Dai, T., Houghten, R. A., Hancock, R. E. W., & Tegos, G. P. (2020). The value of antimicrobial peptides in the age of resistance. The Lancet. Infectious Diseases, 20(9), e216–e230. https://doi.org/10.1016/S1473-3099(20)30327-3

Chicago

Magana, Maria, Muthuirulan Pushpanathan, Ana L Santos, Leon Leanse, Michael Fernandez, Anastasios Ioannidis, Marc A Giulianotti, et al. 2020. “The Value of Antimicrobial Peptides in the Age of Resistance.” The Lancet. Infectious Diseases 20 (9): e216–30. doi:10.1016/S1473-3099(20)30327-3.